The time course of the immune response to experimental coronavirus infection of man

K A Callow, H F Parry, M Sergeant, D A Tyrrell, K A Callow, H F Parry, M Sergeant, D A Tyrrell

Abstract

After preliminary trials, the detailed changes in the concentration of specific circulating and local antibodies were followed in 15 volunteers inoculated with coronavirus 229E. Ten of them, who had significantly lower concentrations of pre-existing antibody than the rest, became infected and eight of these developed colds. A limited investigation of circulating lymphocyte populations showed some lymphocytopenia in infected volunteers. In this group, antibody concentrations started to increase 1 week after inoculation and reached a maximum about 1 week later. Thereafter antibody titres slowly declined. Although concentrations were still slightly raised 1 year later, this did not always prevent reinfection when volunteers were then challenged with the homologous virus. However, the period of virus shedding was shorter than before and none developed a cold. All of the uninfected group were infected on re-challenge although they also appeared to show some resistance to disease and in the extent of infection. These results are discussed with reference to natural infections with coronavirus and with other infections, such as rhinovirus infections.

References

    1. J Med Virol. 1980;5(3):221-9
    1. Infect Immun. 1982 Nov;38(2):419-23
    1. J Biol Chem. 1951 Nov;193(1):265-75
    1. J Hyg (Lond). 1961 Sep;59:309-19
    1. Epidemiol Infect. 1989 Dec;103(3):659-69
    1. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1169-76
    1. Am J Epidemiol. 1966 Sep;84(2):352-63
    1. JAMA. 1970 Feb 16;211(7):1157-61
    1. J Immunol. 1970 Sep;105(3):584-91
    1. J Infect Dis. 1970 Oct;122(4):272-9
    1. Am J Epidemiol. 1971 Jul;94(1):43-9
    1. J Immunol. 1972 Jan;108(1):169-77
    1. Yale J Biol Med. 1974 Dec;47(4):234-51
    1. N Engl J Med. 1976 May 27;294(22):1208-11
    1. J Hyg (Lond). 1976 Jun;76(3):379-93
    1. J Infect Dis. 1977 May;135(5):714-9
    1. Rhinology. 1980 Jun;18(2):87-92
    1. Infect Immun. 1980 Oct;30(1):23-8
    1. J Virol Methods. 1983 May;6(5):267-9
    1. Antimicrob Agents Chemother. 1983 Nov;24(5):713-5
    1. J Med Virol. 1984;13(2):179-92
    1. J Psychosom Res. 1984;28(6):511-23
    1. J Hyg (Lond). 1985 Aug;95(1):173-89
    1. J Infect Dis. 1986 Apr;153(4):743-8
    1. Mil Med. 1986 Sep;151(9):459-65
    1. J Immunol Methods. 1987 Apr 16;98(2):183-7
    1. J Med Virol. 1988 Aug;25(4):475-82
    1. J Infect Dis. 1981 Feb;143(2):252-8
    1. J Psychosom Res. 1980;24(3-4):155-63

Source: PubMed

3
구독하다